Bio-IT World - Next-Gen Technology - Big Data - Personalized Medicine

Time 2021-04-27 19:08:38

Web Name: Bio-IT World - Next-Gen Technology - Big Data - Personalized Medicine

WebSite: http://www.bio-itworld.com

ID:172677

Keywords:

Next,Gen,World,

Description:

New Event Launching in June Focusing on AI for Pharmaceuticals Apr 26 | Bio-IT World | Bio-IT World and AI Trends are pleased to announce DECODE: AI for Pharmaceuticals, June 7-9, 2021, the first cross-functional conference to uncover AI’s true value for the pharmaceutical sector, while also focusing on data strategies, organizational change management, and implementation best practices. More Why Prioritizing Genomic Research Is Critical for The Future of Healthcare Apr 23 | Bio-IT World | Over the past 20 years, the field of genomics has undergone significant progress and transformation. We are at an exciting juncture in this field; however, there is more to be done to ensure more equitable access to technologies and support researchers around the world. More Bioinformatics Platform Designs Therapies Against Multi-Drug Resistant Bacteria Apr 22 | Bio-IT World | A Johns Hopkins University team has published details of their Facile Accelerated Specific Therapeutic (FAST) platform in Nature Communications Biology, a platform designed to address antibiotic resistance. More How COVID-19 Is Changing the Sequencing Landscape Apr 20 | Bio-IT World | The pandemic has prompted diverse scientific groups to take on sequencing in the US—and for many, the new technology has brought additional challenges to overcome. But these NGS-newbies are learning and will change biology beyond COVID-19. More COVID-19 Highlights the Need for Interoperability in Healthcare Apr 16 | Bio-IT World | In healthcare, the primary means of collecting patient data, the electronic health record (EHR), is one of the biggest offenders of a siloed approach to data. One need look no farther than the current pandemic to see how the lack of data-sharing infrastructure has prevented healthcare providers from getting a complete picture of their patients’ medical histories and hindered research on what treatments are working against the novel coronavirus. More Bayer’s Science@Scale Platform and the Role For NVIDIA Federated Learning Apr 15 | Bio-IT World | NVIDIA has announced the next generation of federated learning: Clara 4.0 with global orchestration of edge clients, and an addition to privacy-preserving homomorphic encryption. David Ruau, VP, head of Global Data Assets and Decision Science at Bayer, outlined Bayer’s work with NVIDIA to incorporate Clara Federated Learning. More Mutational Signatures In Cancer Improved By Supervised Machine Learning Apr 14 | Bio-IT World | Researchers at the Johns Hopkins Kimmel Cancer Center have a newly developed supervised machine learning algorithm that does the best job yet of connecting tissue-specific cancers to potential disease-driving factors. More Pharma, Life Sciences Partnerships Driven By NVIDIA AI and Processors Apr 12 | Bio-IT World | At NVIDIA’s GTC event starting this week, NVIDIA CEO Jensen Huang outlined—among other things—partnerships expanding Clara Discovery, NVIDIA’s computational platform for healthcare. More Collaboration Is Key to Combatting Cybercrime Apr 09 | Bio-IT World | Cybersecurity challenges have only escalated during the COVID-19 crisis, particularly in the fields of science and healthcare. The past year has seen a dramatic increase in the number of breaches and ransomware attacks for the enterprise networks of labs and healthcare facilities. More Bora Pharmaceuticals Adds Roller Compaction Capabilities Apr 15 | Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals, has added roller compaction technology to its solid dose capability offerings at its Zhunan, Taiwan contract manufacturing and packaging facility. The Zhunan facility is a leader in the manufacture of complex oral solid dose (OSD) formulations with expertise in the use of solvents, Wurster Coating, or Extrusion-Spheronization. Sterling Pharma Solutions acquires ADC Bio Apr 15 | Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology, a UK based bioconjugation development services business specialising in antibody drug conjugates (ADCs). Qlucore secures SEK 30 million (USD 3.5m) for international expansion Apr 15 | The Swedish AI software company Qlucore AB (“Qlucore” or “the Company”) – with more than 200 international customers – today announces that it has secured SEK 30 million before transaction costs in a pre-IPO private placement. The raised capital will predominantly be used to accelerate sales activities and expand the technical team prior to an initial public offering (IPO), planned within the next twelve months. CD BioSciences Introduces First-in-Human (FIH) Study Service Apr 15 | CD BioSciences, a professional US provider of integrated solutions for clinical trials development, has introduced first-in-human (FIH) study service to biological and pharmaceutical institutes and companies for drug development needs. Genomenon and Limbus Partner to Advance Genomic Variant Interpretation Apr 15 | Genomenon® announced a partnership with Limbus Medical Technologies, which includes integration of the Mastermind® Genomic Search Engine into the cloud-based varvis® platform. In the initial integration available now, users of varvis can preview the number of published articles related to their search and easily link out to view the evidence in Mastermind. A deeper integration using Mastermind’s advanced API is underway, which will allow users to view the relevant evidence right inside the varvis platform. Riffyn s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world s most advanced scientific R D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.Read more here! Digital Therapeutics: Taking digital health to a new levelBenchling is the most widely-adopted life sciences R D cloud. Accelerate, measure, and forecast R D from discovery through bioprocessing all in one place. It s a fully unified platform that centralizes and standardizes all R D data, so you can spend less time fighting with legacy software, and more time reaching breakthrough discoveries.Read more here!

TAGS:Next Gen World 

<<< Thank you for your visit >>>

From systems biology and in silico modeling to cheminformatics and electronic data capture, Bio-IT World shows how predictive information is the key to improving the efficiency of drug discovery, all the way through clinical trials. Critical to the goal of modeling and exploiting information is the IT and informatics infrastructure -- the hardware and software that facilitates the creation of databases, text mining and the conversion of information into hypotheses, models, and conclusions.

Hot Websites